Crinetics Pharmaceuticals, INC DEF 14A proxy statements

Crinetics Pharmaceuticals, Inc. has announced its 2026 Annual Meeting of Shareholders, scheduled for June 18, 2026, to elect directors, ratify auditor selection, and vote on executive compensation.

Crinetics Pharmaceuticals issues a supplement to its proxy statement to correct clerical errors regarding the day of the week for the annual meeting and the deadline for stockholder proposals.

Crinetics Pharmaceuticals will hold its annual stockholders meeting on June 11, 2025, to elect directors, ratify the selection of an independent accounting firm, and conduct an advisory vote on executive compensation.

Crinetics Pharmaceuticals sets June 11, 2025, for its annual stockholder meeting to elect directors, ratify the selection of an independent accounting firm, and conduct an advisory vote on executive compensation.

Crinetics Pharmaceuticals will hold its annual stockholders meeting on June 7, 2024, to vote on director elections, auditor ratification, executive compensation, and other business.

Crinetics Pharmaceuticals will hold its annual meeting of stockholders virtually on June 7, 2024, to vote on director elections, auditor ratification, and executive compensation.